NCT05316467View on ClinicalTrials.gov

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Endometrial CarcinomaObeseOverweightFertility Issues
Interventions
BEHAVIORAL

Intensive Lifestyle Intervention (ILI)

"* dietary guidance~* exercise guidance~* lifestyle intervention"

DRUG

Megestrol Acetate 160 MG Oral Tablet

enrolled participants will take Megestrol Acetate 160mg daily

Trial Locations (1)

200011

RECRUITING

Obstetrics and Gynecology Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Xiaojun Chen

OTHER